- Home
- COO vs SNN Comparison
COO vs SNN Comparison
Compare COO & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COO
- SNN
- Stock Information
- Founded
- COO 1980
- SNN 1856
- Country
- COO United States
- SNN United Kingdom
- Employees
- COO N/A
- SNN N/A
- Industry
- COO Ophthalmic Goods
- SNN Industrial Specialties
- Sector
- COO Health Care
- SNN Health Care
- Exchange
- COO Nasdaq
- SNN Nasdaq
- Market Cap
- COO 14.2B
- SNN 15.2B
- IPO Year
- COO N/A
- SNN 1999
- Fundamental
- Price
- COO $72.45
- SNN $32.63
- Analyst Decision
- COO Buy
- SNN Hold
- Analyst Count
- COO 11
- SNN 4
- Target Price
- COO $79.27
- SNN $32.83
- AVG Volume (30 Days)
- COO 2.1M
- SNN 621.0K
- Earning Date
- COO 12-04-2025
- SNN 10-30-2025
- Dividend Yield
- COO N/A
- SNN 2.24%
- EPS Growth
- COO 13.33
- SNN 59.91
- EPS
- COO 2.04
- SNN 0.56
- Revenue
- COO $4,045,700,000.00
- SNN $5,944,000,000.00
- Revenue This Year
- COO $6.02
- SNN N/A
- Revenue Next Year
- COO $5.81
- SNN N/A
- P/E Ratio
- COO $35.39
- SNN $28.09
- Revenue Growth
- COO 6.35
- SNN 5.35
- 52 Week Low
- COO $61.78
- SNN $23.69
- 52 Week High
- COO $106.63
- SNN $38.79
- Technical
- Relative Strength Index (RSI)
- COO 57.01
- SNN 32.54
- Support Level
- COO $70.64
- SNN $33.05
- Resistance Level
- COO $73.39
- SNN $32.92
- Average True Range (ATR)
- COO 1.54
- SNN 0.49
- MACD
- COO 0.13
- SNN -0.28
- Stochastic Oscillator
- COO 85.95
- SNN 15.79
About COO The Cooper Companies Inc.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.